12:00 AM
Sep 01, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

MVA-HPV-IL2: Phase II start

Next half, the partners will begin an international Phase II trial of TG 4001 in about 200 patients. Roche has exclusive rights to develop...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >